Clinical Trial Update: Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating disulfiram with chelated zinc for treating disseminated metastatic melanoma after failure of first-line therapy; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Chelated Zinc (zinc chelate)
• Disulfiram (Disulfiram)

Snippet

Sponsor: University of Utah | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-28